• 1
    Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 13114.
  • 2
    Marshall BJ, Royce H, Annear DI, et al. Original isolation of Campylobacter pyloritis from human gastric mucosa. Microbiol Lett 1984; 25: 838.
  • 3
    Veldhuyzen van Zanten SJO, Sherman PM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and non-ulcer dyspepsia: a systematic overview. Can Med Assoc J 1994; 150: 17785.
  • 4
    The Eurogast Study Group. An international association between H. pylori infection and gastric cancer. Lancet 1993; 341: 135962.
  • 5
    Hansson LE, Engstrand L, Nyren O, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098103.
  • 6
    Morgner A, Miehlke S, Fischbach W, et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 2001; 19(7): 20418.
  • 7
    Fischbacj W, Goebeler-Kolve M, Starostik P, Greiner A. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 2002; 360: 5478.
  • 8
    Nakamura S, Matsumoto T, Suekane H, et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphoma after eradication of Helicobacter pylori. Gut 2001; 48: 45460.
  • 9
    De Jong D, Vyth-Dreese F, Dellemijn T, et al. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma. J Pathol 2001; 193: 31824.
  • 10
    Ruskone-Fourmestraux A, Labergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001; 48: 297303.
  • 11
    Malfertheiner P, Mégraud F, O'Morain C, et al. Current European concepts in management of H. pylori infection. The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16(2): 16780.
  • 12
    Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating H. pylori. Am J Gastroenterol 1992; 87(12): 171627.
  • 13
    De Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 81720.
  • 14
    Borody TJ, Andrews P, Fracehia G, et al. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995; 37: 47781.
  • 15
    De Boer W. Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1999; 11(7): 697700.
  • 16
    De Boer WA. A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule. Expert Opin Invest Drugs 2001; 10(8): 155966.
  • 17
    De Boer WA, Van Etten RJ, Schneeberger PM, Tytgat GN. A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule. Am J Gastroenterol 2000; 95(3): 6415.
  • 18
    De Boer WA, Van Etten RJ, Van De Wouw BA, Schneeberger PM, Van Oijen AH, Jansen JB. Bismuth-based quadruple therapy for Helicobacter pylori— a single triple capsule plus lansoprazole. Aliment Pharmacol Ther 2000; 14(1): 859.
  • 19
    Veldhuyzen Van Zanten SJO, Farley A, Marcon N, et al. Bismuth subcitrate, metronidazole, and tetracycline HCl in eradication of Helicobacter pylori: a randomised, double-blind study. Can J Gastroenterol 2000; 14(7): 599602.
  • 20
    Lahaie R, Farley A, Dallaire C, et al. Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in eradication of Helicobacter pylori. Can J Gastroenterol 2001; 15(9): 5815.
  • 21
    Laine L, Hunt R, El-Zimaity H, et al. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole and tetracycline given with omeprazole vs. omeprazole, amoxicillin, and clarithromycin for eradication of H. pylori in duodenal ulcer patients. A prospective, randomized, multicenter, North American Trial. AM J Gastroenterol 2003, (in press).
    Direct Link:
  • 22
    Spénard J, Colin P. Is there a difference in eradication rate of Helicobacter pylori between peptic ulcer patients and non-ulcer dyspepsia patients?: a survey of 1666 patients. Gastroenterology 2000; 118(4)(Suppl. 2): A502 (Abstract).